Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2A | P14555 | 2/20 | 0.47 |
| ▸ | BLM | P54132 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 2/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | THRA | P10827 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.40 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.40 |
| ▸ | LTA4H | P09960 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12968212 | 0.93 | DRD2 (0.41) | PLA2G2ABLMTP53ALOX15NR5A1 | |
| SCHEMBL20148279 | 0.89 | PLA2G2A (0.58) | PLA2G2ABLMTP53NR5A1TSHR | |
| SCHEMBL28405359 | 0.89 | PLA2G2A (0.53) | PLA2G2ABLMTP53NR5A1TSHR | |
| SCHEMBL30464049 | 0.89 | PLA2G2A (0.58) | PLA2G2ABLMTP53NR5A1TSHR | |
| SCHEMBL14732481 | 0.89 | PLA2G2A (0.53) | PLA2G2ABLMTP53NR5A1TSHR | |
| SCHEMBL27932265 | 0.89 | PLA2G2A (0.53) | PLA2G2ABLMTP53NR5A1TSHR | |
| SCHEMBL31344503 | 0.89 | PLA2G2A (0.53) | PLA2G2ABLMTP53NR5A1TSHR | |
| SCHEMBL12440948 | 0.87 | ELANE (0.43) | TP53ALOX15LTA4HALDH1A1HTT | |
| SCHEMBL1070543 | 0.87 | TP53 (0.56) | PLA2G2ABLMTP53ALOX15NR5A1 | |
| SCHEMBL12550198 | 0.87 | PLA2G2A (0.59) | PLA2G2ABLMTP53ALOX15NR5A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180205242-A1 | CAPACITOR BASED POWER SYSTEM AND UNMANNED VEHICLE WITH THE CAPACITOR BASED POWER SYSTEM THEREOF | CAPACITOR SCIENCES INCORPORATED | 2018-07-19 | — | — | US | disclosed |
| US-20180137978-A1 | HEIN ELECTRO-POLARIZABLE COMPOUND AND CAPACITOR THEREOF | CAPACITOR SCIENCES INCORPORATED | 2018-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180137978-A1 | HEIN ELECTRO-POLARIZABLE COMPOUND AND CAPACITOR THEREOF | HCN2, KCNE1, KCNN2 | PLA2G2A 2763/4885BLM 1032/4885TP53 3029/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.